Skip to main content

J K Pharmachem Share Price

₹ 1.79

-0.03(1.65%)
Price as of 21 Nov 2026 00:12. Log in to view Live prices

J K Pharmachem is delisted from BSE

J K Pharmachem Share Price Chart

J K Pharmachem Performance

Days Range

Low: ₹1.76

High: ₹1.90

Previous Close₹1.82
Open₹N/A
VolumeN/A
Day's Range₹1.76 - ₹1.90
52W Range₹0.00 - ₹1.90
Market Cap₹11.22 Cr

J K Pharmachem Fundamentals

ROCE(TTM)0.00
P/E Ratio (TTM)-1.37
P/B RatioN/A
Industry P/E51.77
Debt to EquityN/A
ROE0.00
EPS (TTM)N/A
Dividend YieldN/A
Book Value-5.97
Face Value10
ROCE(TTM)0.00
P/E Ratio (TTM)-1.37
P/B RatioN/A
Industry P/E51.77
Debt to EquityN/A
ROE0.00
EPS (TTM)N/A
Dividend YieldN/A
Book Value-5.97
Face Value10

J K Pharmachem Financials

Error fetching financial data!!

About J K Pharmachem

Jointly promoted by J K Industries and TIDCO, J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.'94 to part-finance the setting up of a plant to manufacture 1250 MMU P.a of pencillin-G, based on a microbial strain from the technical collaborators -- IGC (Cyprus), Cyprus -- a wholly-owned subsidiary of ICN Galenika. Commercial production at this plant commenced in Oct.'95. The company has a tie-up with ICN Galenika, part of the ICN Pharmaceuticals group (one of the pioneering manufacturers of pencillin-G), to set up a 1250-mmu capacity plant. It has already produced international standard penicillin with Indian raw materials, at its collaborator's plant which is among the best in the world. In addition, J K Pharmachem had set-up its own R&D activity well in advance for future development in the field of bio-technology. A pilot plant is also being established for this purpose at Cuddalore, Tamilnadu. The company also plans to diversify into speciality fermentation products. It has also started production of Penicillin-V and is the only one in India to produce this bulk active. During 1999-2000, the company started the production of Penicillin V and is the only producer of this important bulk active in India. The accumulated losses of the company having exceeded 50% of the peak networth of the company in the immediately preceding four financial years, the company took the necessary steps of SICA, 1985. The company developed an in-house and launched viz JKZyme, an environment new product of paper & pulp. Commercial trails are under way in India and abroad. The company has produced 1192 MMU of Penicillin-G during the financial year 2003-04 and retained its status as the second largest producer with a market share of 24%.

Parent Organisation
Singhania Hari S
Managing Director
NA
Founded
1990
NSE Symbol
JKPHARMA

J K Pharmachem Share Price History

Data is not available currently. Please check back later.

Top Mutual Funds Invested in J K Pharmachem Share

Data is not available currently. Please check back later.

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,892.0Price decrease
-8.00 (-0.42%)
₹4,56,593.441,583.7 - 2,046.9
Divis Laboratories Ltd11,137.5Price decrease
-40.50 (-0.36%)
₹2,96,740.785,647.5 - 11,824.0
Torrent Pharmaceuticals Ltd4,665.0Price increase
54.00 (1.17%)
₹1,75,577.803,672.3 - 5,250.0
Laurus Labs Ltd2,297.0Price decrease
-9.00 (-0.39%)
₹1,24,379.87917.95 - 2,488.0
Zydus Lifesciences Ltd1,199.9Price decrease
-3.00 (-0.25%)
₹1,19,700.46835.5 - 1,266.6
Dr Reddys Laboratories Ltd1,388.0Price decrease
-12.90 (-0.92%)
₹1,16,770.961,101.0 - 1,414.9

J K Pharmachem Ltd FAQs

Yes, You can buy J K Pharmachem Ltd (JKPHARMA) shares by opening a Demat account with Angel One.
J K Pharmachem Ltd (JKPHARMA) share can be bought through the following modes:
1. Direct investment: You can buy J K Pharmachem Ltd (JKPHARMA) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to J K Pharmachem Ltd (JKPHARMA) shares.